Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Leleu

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Leukemia|January 28, 2005
Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21)H Leroy, S de Botton, N Grardel-Duflos, et al.
Leukemia|May 26, 2012
Reduced steady state-based peripheral blood stem cell harvest rate in multiple myeloma treated with bortezomib-based induction regimensS Manier, M Barthelemy, G Fouquet, et al.
Leukemia|March 8, 2019
Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Leukemia|December 20, 2017
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Oncogene|April 21, 2015
Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström macroglobulinemiaB T Gaudette, B Dwivedi, K S Chitta, et al.
La Revue De Medecine Interne|January 19, 2015
[Monoclonal gammopathies of undetermined significance do not systematically require a specialized consultation]G Fouquet, K Amouzou, L Renaud, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
Effectiveness of second-line treatment in AL amyloidosis patient's refractory to M-DexA Penot, J Abraham, H Debarri, et al.
La Revue De Medecine Interne|April 6, 2010
[Waldenström's macroglobulinemia]S Poulain, M Wemeau, S Balkaran, et al.
Blood|March 10, 2001
Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapyT Facon, H Avet-Loiseau, G Guillerm, et al.
Leukemia|May 12, 2017
Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myelomaM Favreau, E Menu, D Gaublomme, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Leukemia|January 28, 2005
Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21)H Leroy, S de Botton, N Grardel-Duflos, et al.
Leukemia|May 26, 2012
Reduced steady state-based peripheral blood stem cell harvest rate in multiple myeloma treated with bortezomib-based induction regimensS Manier, M Barthelemy, G Fouquet, et al.
Leukemia|March 8, 2019
Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Leukemia|December 20, 2017
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Oncogene|April 21, 2015
Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström macroglobulinemiaB T Gaudette, B Dwivedi, K S Chitta, et al.
La Revue De Medecine Interne|January 19, 2015
[Monoclonal gammopathies of undetermined significance do not systematically require a specialized consultation]G Fouquet, K Amouzou, L Renaud, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
Effectiveness of second-line treatment in AL amyloidosis patient's refractory to M-DexA Penot, J Abraham, H Debarri, et al.
La Revue De Medecine Interne|April 6, 2010
[Waldenström's macroglobulinemia]S Poulain, M Wemeau, S Balkaran, et al.
Blood|March 10, 2001
Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapyT Facon, H Avet-Loiseau, G Guillerm, et al.
Leukemia|May 12, 2017
Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myelomaM Favreau, E Menu, D Gaublomme, et al.
Pageof 6